Seneca is on their last year of funds and they lost their value when their clinical trials for their ALS product failed. But that failure is kind of disputed by their scientists. They just recently fired a bunch of their staff, renamed themselves, built a new manufacturing lab in China, and won a new patent from the FDA in the US this march. When you listen to the Head Scientist for Seneca or read Seneca's website, their narratives always sound a little vague and uncertain, like they are further from their ambitions then they are expressing but would like to renew their funds and continue anyway. Their ALS clinical trial is now in its third wave but Seneca's scientist gave a hesitant and uncertain 'soon' as the response as to when the results for that study will be revealed. They have now patented the use of neuronal stem cells to help assist in brain injuries and they are doing clinical studies around that right now. Research companies often have fluctuations in their value because profitable products are not consistent, they take a lot of time and failure to create. Im having a difficult time understanding if Seneca is building an amazing, ambitious product and shareholders are being impatient with the process or if Seneca is kind of just a sneaky corporation using an innovative scientific veneer to continue building funds for themselves. Their shares are currently hovering around .80 cents and if they go back to the $500/share excitement of 2015 when they first expressed their research goals, then you could make a really nice profit. I think they are building up the veneer and the narrative of success right now and if they manipulated their share value somehow at a critical time when they've announced their new product, they could create enough confidence for people to flock to their stock and then share prices will definitely go up. They also just moved abroad and may be able to garner enough attention there to renew their funds. I feel like they are currently making the correct choices and people are watching them and at any moment that their share prices begin moving up, a lot of people will begin investing in them.
